Renal toxicity and osteonecrosis of the jaw in cancer patients treated with bisphosphonates: a long-term retrospective analysis.

PubWeight™: 1.47‹?› | Rank: Top 5%

🔗 View Article (PMID 19330470)

Published in Med Oncol on March 28, 2009

Authors

M Bonomi1, R Nortilli, A Molino, T Sava, A Santo, A Caldara, G L Cetto

Author Affiliations

1: Department of Clinical and Experimental Medicine, Division of Medical Oncology, University of Verona, Ple LAScuro 10, 37134 Verona, Italy.

Articles by these authors

Paroxysmal atrial fibrillation in myotonic dystrophy type 1 patients: P wave duration and dispersion analysis. Eur Rev Med Pharmacol Sci (2015) 2.86

Prospective randomized trial of docetaxel versus mitomycin plus vinblastine in patients with metastatic breast cancer progressing despite previous anthracycline-containing chemotherapy. 304 Study Group. J Clin Oncol (1999) 1.98

Preoperative staging of primary breast cancer. A multicentric study. Cancer (1988) 1.56

High-dose chemotherapy supported with autologous bone marrow transplantation (ABMT) in germ cell tumors: a phase two study. Ann Oncol (1992) 1.53

Complement receptor (CR1) and IgG or IgA on erythrocytes and in circulating immune complexes in patients with glomerulonephritis. Nephrol Dial Transplant (1989) 1.42

Small cell lung cancer. Ann Oncol (2006) 1.30

Ki-67 immunostaining in 322 primary breast cancers: associations with clinical and pathological variables and prognosis. Int J Cancer (1997) 1.12

A randomized, controlled phase III study of cyclophosphamide, doxorubicin, and vincristine with etoposide (CAV-E) or teniposide (CAV-T), followed by recombinant interferon-alpha maintenance therapy or observation, in small cell lung carcinoma patients with complete responses. Cancer (1997) 1.11

Immuno-histological analysis of bone marrow involvement in lymphoproliferative disorders. Br J Haematol (1982) 1.10

Phase II randomized study of dacarbazine, carmustine, cisplatin and tamoxifen versus dacarbazine alone in advanced melanoma patients. Melanoma Res (2001) 1.06

Familial outbreak of disseminated multidrug-resistant tuberculosis and meningitis. Int J Tuberc Lung Dis (2001) 1.06

Prognostic significance of estrogen receptors in 405 primary breast cancers: a comparison of immunohistochemical and biochemical methods. Breast Cancer Res Treat (1997) 1.06

Effects of a gluten-free diet in primary IgA nephropathy. Clin Nephrol (1990) 1.03

Completion pneumonectomy for non-small cell lung cancer: experience with 59 cases. Eur J Cardiothorac Surg (2002) 1.00

A comparative analysis of three different techniques for the detection of breast cancer cells in bone marrow. Cancer (1991) 0.99

Inductively coupled plasma mass spectroscopy quantitation of platinum-DNA adducts in peripheral blood leukocytes of patients receiving cisplatin- or carboplatin-based chemotherapy. Clin Cancer Res (1996) 0.97

Detection of a soluble form of the receptor for interleukin 2 in the serum of patients with hairy cell leukaemia. Int J Biol Markers (1988) 0.94

Pemetrexed in combination with oxaliplatin as a first-line therapy for advanced gastric cancer: a multi-institutional phase II study. Ann Oncol (2009) 0.93

Changes in bioimpedance analysis after stable refeeding of undernourished anorexic patients. Int J Obes Relat Metab Disord (1999) 0.93

Dynamic changes of live/apoptotic circulating tumour cells as predictive marker of response to sunitinib in metastatic renal cancer. Br J Cancer (2012) 0.93

Efficacy and tolerability of azithromycin versus amoxicillin/clavulanic acid in acute purulent exacerbation of chronic bronchitis. J Chemother (1995) 0.91

Familial and environmental influences on body composition and body fat distribution in childhood in southern Italy. Int J Obes Relat Metab Disord (1994) 0.91

Mediastinal large-B-cell lymphoma with sclerosis: a clinical study of 21 patients. J Clin Oncol (1990) 0.91

bcl-2 but not p53 expression is associated with resistance to chemotherapy in advanced breast cancer. Clin Cancer Res (1998) 0.91

Quality of life evaluation in a randomised trial of chemotherapy versus bio-chemotherapy in advanced melanoma patients. Eur J Cancer (2003) 0.90

Framing of outcome and probability of recurrence: breast cancer patients' choice of adjuvant chemotherapy (ACT) in hypothetical patient scenarios. Breast Cancer Res Treat (2000) 0.90

Correlations between family history and cancer characteristics in 2256 breast cancer patients. Br J Cancer (2004) 0.89

Scleral buckling surgery in stage 4 retinopathy of prematurity. Graefes Arch Clin Exp Ophthalmol (1996) 0.88

Postoperative chemotherapy increases the disease-free survival rate in primary gastric lymphomas stage IE and IIE. Eur J Cancer (1994) 0.88

Biology, prognosis and response to therapy of breast carcinomas according to HER2 score. Ann Oncol (2008) 0.88

Cisplatin versus carboplatin in combination with mitomycin and vinblastine in advanced non small cell lung cancer. A multicenter, randomized phase III trial. Lung Cancer (2004) 0.88

Bioelectrical impedance phase angle in constitutionally lean females, ballet dancers and patients with anorexia nervosa. Eur J Clin Nutr (2008) 0.86

Tumor proliferative activity and response to first-line chemotherapy in advanced breast carcinoma. Breast Cancer Res Treat (1996) 0.86

Long nocturnal dialysis. Blood Purif (2002) 0.86

Agreement between oncology guidelines and clinical practice in Italy: the 'right' program. A project of the Italian Association of Medical Oncology (AIOM). Ann Oncol (2007) 0.85

Use of the ratio of time to progression following first- and second-line therapy to document the activity of the combination of oxaliplatin with 5-fluorouracil in the treatment of colorectal carcinoma. Ann Oncol (2001) 0.85

Erythrocyte cation content, globin chain synthesis and glucose metabolism in dysmyelopoietic syndromes. Acta Haematol (1982) 0.85

Body composition changes in patients with anorexia nervosa after complete weight recovery. Eur J Clin Nutr (2002) 0.85

Carboplatin, doxorubicin and etoposide in the treatment of tumours of unknown primary site. Br J Cancer (2004) 0.84

Bone marrow micrometastases in 109 breast cancer patients: correlations with clinical and pathological features and prognosis. Breast Cancer Res Treat (1997) 0.84

Cell cycle genes as targets of retinoid induced ovarian tumor cell growth suppression. Oncogene (2001) 0.84

Weekly gemcitabine and cisplatin in advanced non-small-cell lung cancer: a phase II study. Ann Oncol (1999) 0.83

A late complication of transobturator tape: abscess and myositis. Minerva Ginecol (2008) 0.82

Comparative study of clinical, pathological and biological characteristics of symptomatic versus asymptomatic breast cancers. Ann Oncol (2000) 0.82

IgA antibodies to dietary antigens and lectin-binding IgA in sera from Italian, Australian, and Japanese IgA nephropathy patients. Am J Kidney Dis (1991) 0.82

Cisplatin pharmacokinetics using a five-day schedule during repeated courses of chemotherapy in germ cell tumors. Ther Drug Monit (1995) 0.81

Bone marrow micrometastases in breast cancer patients. Breast Cancer Res Treat (1999) 0.81

Estrogen receptors in 699 primary breast cancers: a comparison of immunohistochemical and biochemical methods. Breast Cancer Res Treat (1995) 0.81

The fate of aggregated immunoglobulin A injected in IgA nephropathy patients and healthy controls. Am J Kidney Dis (1991) 0.81

Sparing of function after infant lesions of selected limbic structures in the rat. J Comp Physiol Psychol (1975) 0.81

[Value of tumor marker positivity in germinal non-seminomatous tumors of the testis]. J Nucl Med Allied Sci (1991) 0.81

Clearance of polymeric IgA aggregates in humans. Am J Kidney Dis (1989) 0.80

Bone marrow evaluation: the relative merits of particle sections and smear preparations. Appl Pathol (1983) 0.80

Role of monocytes in cryoglobulinemia-associated nephritis. Kidney Int (1993) 0.80

Positive immunostaining with MLuC1 of bone marrow aspirate predicts poor outcome in patients with small-cell lung cancer. Ann Oncol (1998) 0.79

Estrogen and progesterone receptors in breast cancer: correlation with clinical and pathological features and with prognosis. Oncology (1992) 0.79

Cytotoxic in vitro function in patients with metastatic renal cell carcinoma before and after alpha-2b-interferon therapy. Effects of activation with recombinant interleukin-2. Cancer (1992) 0.79

A double blind randomized study of oral clodronate in the treatment of bone metastases from tumors poorly responsive to chemotherapy. J Exp Clin Cancer Res (1998) 0.79

Oxygen-induced retinopathy in the newborn rat: effects of hyperbarism and topical administration of timolol maleate. Graefes Arch Clin Exp Ophthalmol (1995) 0.78

Measurement of vascular access recirculation unaffected by cardiopulmonary recirculation: evaluation of an ultrasound method. Nephron (1999) 0.78

Neoadjuvant high dose chemotherapy plus peripheral blood progenitor cells in inflammatory breast cancer: a multicenter phase II pilot study. Haematologica (2001) 0.78

Mastectomy and immediate breast reconstruction: oncological considerations and evaluation of two different methods relating to 88 cases. Eur J Surg Oncol (1995) 0.78

High pathological response rate in locally advanced esophageal cancer after neoadjuvant combined modality therapy: dose finding of a weekly chemotherapy schedule with protracted venous infusion of 5-fluorouracil and dose escalation of cisplatin, docetaxel and concurrent radiotherapy. Ann Oncol (2005) 0.78

Multicentric phase II trial of gemcitabine plus epirubicin plus paclitaxel as first-line chemotherapy in metastatic breast cancer. Br J Cancer (2004) 0.78

Kinetics and fate of IgA-IgG aggregates as a model of naturally occurring immune complexes in IgA nephropathy. Lab Invest (1992) 0.78

Detection at diagnosis of tumor cells in bone marrow aspirates of patients with small-cell lung cancer (SCLC) and clinical correlations. Ann Oncol (1995) 0.78

Effect of light on oxygen-induced retinopathy in the rat model. Light and OIR in the rat. Doc Ophthalmol (1991) 0.77

Immunocytochemical assessment of bone marrow aspirates for monitoring response to chemotherapy in small-cell lung cancer patients. Br J Cancer (1999) 0.77

AFP and HCG in germ cell tumors. Int J Biol Markers (1994) 0.77

Cisplatin pharmacokinetics in elderly patients. Ther Drug Monit (1994) 0.77

Peritoneal dialysis compared with hemodialysis in the treatment of end-stage renal disease. J Nephrol (2001) 0.77

Urea rebound and effectively delivered dialysis dose. Nephrol Dial Transplant (1998) 0.77

Increased plasma endothelin in diabetes: an atherosclerosis marker? Diabetologia (1994) 0.76

Detection of normal and malignant megakaryocytes by anti beta-thromboglobulin serum. An immunofluorescence study. Scand J Haematol (1982) 0.76

Amygdala lesions and CER learning: long term effect of kindling. Physiol Behav (1972) 0.76

Cation content and membrane deformability of heterozygous beta-thalassaemic red blood cells. Br J Haematol (1974) 0.76

Neo-adjuvant chemotherapy in non-small cell lung cancer (NSCLC). Ann Oncol (2006) 0.76

Identifying optimal adjuvant treatment for individual patients: young age is still an issue? Ann Oncol (2009) 0.75

Iris vascular changes in newborns of diabetic mothers. Ophthalmologica (1998) 0.75

[Surgery and chemotherapy in the treatment of primary gastric lymphomas: case review]. Chir Ital (1993) 0.75

Independent expression of p55 and p75 interleukin-2 receptors (IL-2R) during intravenous or subcutaneous administration of recombinant interleukin-2 (rIL-2) by T-lymphocytes and natural killer cells. Cancer (1994) 0.75

Does bone marrow involvement affect prognosis in small-cell lung cancer? Ann Oncol (1998) 0.75

Detection of small-cell-lung-cancer cells in bone-marrow aspirates by monoclonal antibodies NCC-LU-243, NCC-LU-246 and MLuC1. Int J Cancer Suppl (1994) 0.75